ＪＣＲファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/06/21 | 1,348 | 1,351.5 | 1,313.5 | 1,314 | -42.5 | -3.1% | 520,500 |
| 2023/06/20 | 1,365.5 | 1,369 | 1,338.5 | 1,356.5 | -18.5 | -1.3% | 313,500 |
| 2023/06/19 | 1,361 | 1,405.5 | 1,361 | 1,375 | +28 | +2.1% | 445,000 |
| 2023/06/16 | 1,339.5 | 1,374.5 | 1,333 | 1,347 | +28 | +2.1% | 671,100 |
| 2023/06/15 | 1,370 | 1,376 | 1,319 | 1,319 | -59 | -4.3% | 387,700 |
| 2023/06/14 | 1,384 | 1,391 | 1,368.5 | 1,378 | +7 | +0.5% | 365,800 |
| 2023/06/13 | 1,395 | 1,399 | 1,365 | 1,371 | -25 | -1.8% | 379,900 |
| 2023/06/12 | 1,385 | 1,422.5 | 1,372.5 | 1,396 | +25.5 | +1.9% | 472,300 |
| 2023/06/09 | 1,379 | 1,388 | 1,357 | 1,370.5 | +9.5 | +0.7% | 522,400 |
| 2023/06/08 | 1,384 | 1,384 | 1,350.5 | 1,361 | -17.5 | -1.3% | 557,100 |
| 2023/06/07 | 1,414 | 1,414 | 1,364 | 1,378.5 | -22 | -1.6% | 617,900 |
| 2023/06/06 | 1,400 | 1,414.5 | 1,371 | 1,400.5 | -18 | -1.3% | 542,300 |
| 2023/06/05 | 1,421 | 1,424 | 1,385.5 | 1,418.5 | +7.5 | +0.5% | 430,200 |
| 2023/06/02 | 1,362 | 1,413 | 1,346 | 1,411 | +34 | +2.5% | 523,500 |
| 2023/06/01 | 1,353 | 1,397 | 1,339 | 1,377 | +40 | +3% | 485,400 |
| 2023/05/31 | 1,358 | 1,364 | 1,328 | 1,337 | -51 | -3.7% | 753,500 |
| 2023/05/30 | 1,377 | 1,406 | 1,354 | 1,388 | +11 | +0.8% | 295,600 |
| 2023/05/29 | 1,370 | 1,419 | 1,335 | 1,377 | +26 | +1.9% | 604,200 |
| 2023/05/26 | 1,405 | 1,406 | 1,344 | 1,351 | -72 | -5.1% | 619,300 |
| 2023/05/25 | 1,441 | 1,455 | 1,412 | 1,423 | -29 | -2% | 514,200 |
| 2023/05/24 | 1,463 | 1,480 | 1,446 | 1,452 | -27 | -1.8% | 665,300 |
| 2023/05/23 | 1,410 | 1,518 | 1,409 | 1,479 | +102 | +7.4% | 1,584,300 |
| 2023/05/22 | 1,369 | 1,381 | 1,331 | 1,377 | -7 | -0.5% | 1,003,500 |
| 2023/05/19 | 1,301 | 1,405 | 1,301 | 1,384 | +149 | +12.1% | 2,552,000 |
| 2023/05/18 | 1,174 | 1,243 | 1,169 | 1,235 | +109 | +9.7% | 1,204,900 |
| 2023/05/17 | 1,135 | 1,155 | 1,108 | 1,126 | -1 | -0.1% | 637,500 |
| 2023/05/16 | 1,166 | 1,166 | 1,119 | 1,127 | -23 | -2% | 978,100 |
| 2023/05/15 | 1,194 | 1,199 | 1,133 | 1,150 | -43 | -3.6% | 1,242,500 |
| 2023/05/12 | 1,319 | 1,322 | 1,182 | 1,193 | -237 | -16.6% | 1,677,500 |
| 2023/05/11 | 1,431 | 1,443 | 1,425 | 1,430 | -13 | -0.9% | 268,400 |
| 2023/05/10 | 1,462 | 1,462 | 1,435 | 1,443 | -15 | -1% | 206,000 |
| 2023/05/09 | 1,426 | 1,463 | 1,415 | 1,458 | +24 | +1.7% | 295,800 |
| 2023/05/08 | 1,453 | 1,457 | 1,425 | 1,434 | -25 | -1.7% | 224,600 |
| 2023/05/02 | 1,473 | 1,484 | 1,445 | 1,459 | +8 | +0.6% | 298,400 |
| 2023/05/01 | 1,465 | 1,480 | 1,437 | 1,451 | -12 | -0.8% | 221,900 |
| 2023/04/28 | 1,456 | 1,473 | 1,440 | 1,463 | +33 | +2.3% | 266,700 |
| 2023/04/27 | 1,428 | 1,445 | 1,423 | 1,430 | -13 | -0.9% | 305,200 |
| 2023/04/26 | 1,460 | 1,485 | 1,439 | 1,443 | -31 | -2.1% | 247,600 |
| 2023/04/25 | 1,466 | 1,488 | 1,465 | 1,474 | +1 | +0.1% | 151,700 |
| 2023/04/24 | 1,474 | 1,485 | 1,465 | 1,473 | +10 | +0.7% | 153,300 |
| 2023/04/21 | 1,466 | 1,466 | 1,438 | 1,463 | -4 | -0.3% | 214,900 |
| 2023/04/20 | 1,482 | 1,483 | 1,465 | 1,467 | -23 | -1.5% | 286,500 |
| 2023/04/19 | 1,481 | 1,499 | 1,476 | 1,490 | -19 | -1.3% | 247,200 |
| 2023/04/18 | 1,505 | 1,514 | 1,494 | 1,509 | +22 | +1.5% | 204,200 |
| 2023/04/17 | 1,501 | 1,505 | 1,473 | 1,487 | -25 | -1.7% | 253,900 |
| 2023/04/14 | 1,497 | 1,521 | 1,495 | 1,512 | +61 | +4.2% | 457,700 |
| 2023/04/13 | 1,452 | 1,476 | 1,446 | 1,451 | -12 | -0.8% | 283,000 |
| 2023/04/12 | 1,490 | 1,497 | 1,460 | 1,463 | -23 | -1.5% | 275,800 |
| 2023/04/11 | 1,478 | 1,503 | 1,477 | 1,486 | +26 | +1.8% | 341,800 |
| 2023/04/10 | 1,447 | 1,467 | 1,441 | 1,460 | +1 | +0.1% | 264,700 |
351～
400
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「ＪＣＲファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＪＣＲファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
